{
    "snomed_indications": [
        {
            "reasoning": "Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.",
            "extracted_at": "2025-08-02T00:13:01.308",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "Hypothyroidism",
            "confidence": 0.9,
            "snomed_code": "116410007"
        }
    ],
    "drug_name": "Levothyroxine",
    "metadata": {
        "total_indications_found": 1,
        "approach": "drugbank_snomed_extraction",
        "model_used": "llama3.2",
        "confirmation_rate_percent": 100,
        "processing_time_seconds": 18.688395023345947,
        "confidence_threshold": 0.6,
        "confirmed_indications": 1,
        "original_indication_text": "Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.",
        "processing_timestamp": "2025-08-02T00:13:01.308"
    },
    "debug_info": {
        "processing_notes": "Successful SNOMED CT extraction from DrugBank text",
        "failure_reason": "",
        "indication_text_length": 311,
        "llm_failed": false,
        "raw_llm_response": "Research Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE: 116410007\nSNOMED_TERM: Hypothyroidism\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\n\nResearch Finding N:\nSNOMED_CODE"
    }
}